USJECT

Serial Number 98213336
731

Registration Progress

Application Filed
Oct 6, 2023
Under Examination
Aug 27, 2024
Approved for Publication
Jul 2, 2024
Published for Opposition
Jul 2, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Feb 27, 2026 60 days

Trademark Image

USJECT

Basic Information

Serial Number
98213336
Filing Date
October 6, 2023
Published for Opposition
July 2, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
Aug 25, 2025
Application
Pending
Classes
005 010 042

Rights Holder

UNITHER PHARMACEUTICALS

99
Address
151 rue André Durouchez
Espace Industriel Nord, CS 28028
80084 AMIENS -
FR

Ownership History

UNITHER PHARMACEUTICALS

Original Applicant
99
80084 AMIENS FR

UNITHER PHARMACEUTICALS

Owner at Publication
99
80084 AMIENS FR

Legal Representation

Attorney
Rebeccah Gan

USPTO Deadlines

Next Deadline
60 days remaining
NOA E-Mailed - SOU Required
Due Date
February 27, 2026
Extension Available
Until August 27, 2026

Application History

21 events
Date Code Type Description Documents
Aug 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 25, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 25, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 25, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 27, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 12, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 28, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 28, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 28, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 28, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 28, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 28, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 17, 2023 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 15, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medical preparations, namely, sanitary preparations for medical use, antibiotics, pain relief medication, vaccine preparations, anticoagulants, and hormonal, neurological and cardiac medication; injectable pharmaceutical products, namely, antibiotics, pain relief medication, vaccine preparations, anticoagulants, and hormonal, neurological and cardiac medication; syringes pre-filled with pharmaceutical products for medical use in the nature of sanitary preparations for medical use, antibiotics, pain relief medication, vaccine preparations, anticoagulants, and hormonal, neurological and cardiac medication; diagnostic preparations for medical purposes
Class 010
Medical apparatus and instruments for injection being injection device for pharmaceuticals, injection needles, and injection syringes; injectors for medical use, namely, medical fluid injectors; injection devices for pharmaceutical products being injection device for pharmaceuticals; containers for medical samples, namely, capillary tubes for samples for medical use, medical specimen collection devices in the nature of cups for the collection of urine; syringes for medical purposes; injection needles for medical and surgical use; needle holders for surgical use being attachments for medical injection devices to aid in holding injection needles perpendicular to the skin
Class 042
Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research and development of injection devices for pharmaceutical use

Additional Information

Design Mark
The mark consists of the stylized wording “USJECT” in which the stylized letters “US” are featured in red, white, and blue and feature various white star designs, which is to resemble an incomplete stylized American flag design, and the stylized letters “JECT” are featured in turquoise. A design of a syringe featured in turquoise and light turquoise with a single droplet design positioned at the end of the syringe that is also featured in turquoise and light turquoise is positioned above the stylized wording “USJECT”. The stylized wording and designs, as illustrated in the mark, are featured on top of a transparent rectangular background, which is not a claimed feature of the mark.
Color Claim
The color(s) red, white, blue, turquoise, and light turquoise is/are claimed as a feature of the mark.
Pseudo Mark
US INJECT

Classification

International Classes
005 010 042